Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant ascites

S L Parsons1, S A Watson, R J Steele

  • 1Department of Surgery, University Hospital, Nottingham, UK.

The British Journal of Surgery
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Malignant ascites management by general surgeons is challenging. This review proposes a new treatment strategy based on tumor type to balance benefits and reduce patient morbidity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A decade of the Oesophageal Cancer Clinical and Molecular Stratification Consortium.

Nature medicine·2023
Same author

Anaesthetic recruitment interview performance and ethnicity.

Anaesthesia·2023
Same author

Label-free quantitative SWATH-MS proteomic analysis of adult myocardial slices in vitro after biomimetic electromechanical stimulation.

Scientific reports·2022
Same author

A practical guide for investigating cardiac physiology using living myocardial slices.

Basic research in cardiology·2020
Same author

Author response to: Defining true impact of anastomotic leaks after oesophagogastric cancer surgery.

The British journal of surgery·2020
Same author

Adjuvant statin therapy for oesophageal adenocarcinoma: the STAT-ROC feasibility study.

BJS open·2020
Same journal

Making the OR work: a socio-material study of ergonomics in the operating room.

The British journal of surgery·2026
Same journal

A randomized, noninferiority clinical trial of Single-Shot Intrathecal Morphine versus Continuous Wound Infiltration for postoperative pain control after open pancreatoduodenectomy.

The British journal of surgery·2026
Same journal

Trimester-Specific Safety of Laparoscopic versus Open Abdominal Surgery During Pregnancy: A Systematic Review and Meta-analysis.

The British journal of surgery·2026
Same journal

The Gut Microbiome in Surgical Oncology: Mechanisms, Perioperative Outcomes, and Therapeutic Opportunities.

The British journal of surgery·2026
Same journal

Patient-led, home-based follow-up for colorectal cancer: the DISTANCE multicentre stepped-wedge cluster-randomised trial.

The British journal of surgery·2026
Same journal

Correction to: Reduced secretory efficiency in parathyroid carcinoma: diagnostic value of the PTH-to-tumour-volume ratio.

The British journal of surgery·2026
See all related articles

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gastroenterology

Background:

  • Malignant ascites presents a complex clinical challenge, frequently managed by general surgeons.
  • Understanding the etiology and pathophysiology is crucial for effective treatment.

Purpose of the Study:

  • To review current and novel therapeutic options for malignant ascites.
  • To propose an optimized management regimen tailored to the specific tumor of origin.

Main Methods:

  • Literature review of established and emerging treatment modalities.
  • Analysis of etiological and pathophysiological factors.
  • Development of a tumor-specific management algorithm.

Main Results:

  • Current treatments for malignant ascites have limitations.

Related Experiment Videos

  • A knowledge-based approach to management can potentially improve outcomes.
  • Balancing therapeutic benefit with treatment-related morbidity is key.

    • Conclusions:

    • A tailored management strategy for malignant ascites, considering the tumor type, is proposed.
    • This approach aims to optimize patient outcomes by minimizing morbidity.
    • Further investigation into novel therapeutic options is warranted.